Editorial Board
Academic Editors
- Salah Aref
, Hematology Unit; Clinical Pathology Department; Mansoura University, Egypt - Eduardo Arellano-Rodrigo, Hospital Clínic de Barcelona, Spain
- Emmanuel Bissé, Universitätsklinikum Freiburg, Germany
- Massimo Breccia, Universita degli Studi di Roma La Sapienza, Italy
- Saveria Capria, Sapienza University of Rome , Italy
- Sylvain Choquet, Hôpital de la Pitié-Salpêtrière, France
- Stephen E. Langabeer, Cancer Molecular Diagnostics Central Pathology Laboratory St. James’s Hospital, Ireland
- Gergely Feher, Department of Neurology, Szigetvar Hospital, Hungary
- John Frater, Washington University, Saint Louis, USA
- Dennis Galanakis, Stony Brook University, USA
- Neelam Giri, National Institutes of Health, USA
- Tomás J. González-López, University Hospital of Burgos, Spain
- Alessandro Gozzetti, University of Siena, Italy
- Chihaya Imai, Niigata University, Japan
- Kiyotaka Kawauchi, Tokyo Women's Medical University, Japan
- Kostas Konstantopoulos, National and Kapodistrian University of Athens, Greece
- Marie-Christine Kyrtsonis, National and Kapodestrian University of Athens, Greece
- Giuseppe Murdaca, Università degli Studi di Genova, Italy
- Masayuki Nagasawa, Tokyo Medical & Dental University, Japan
- Kazunori Nakase, Mie University, Japan
- Tatsuharu Ohno, Ohtsu Red Cross Hospital, Japan
- Akimichi Ohsaka, Juntendo University, Japan
- Sotirios G. Papageorgiou, University General Hospital Attikon, Greece
- Pier Paolo Piccaluga, Bologna University School of Medicine, Italy
- Håkon Reikvam, University of Bergen, Norway
- Vincent Ribrag, Gustave Roussy Comprehensive Cancer Center , France
- Domenico Russo, Unit of Blood Disease and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, AO Spedali Civili di Brescia, Italy, Italy
- Yusuke Shiozawa, Wake Forest University School of Medicine, USA
- Takashi Sonoki, Wakayama Medical University, Japan
- Sergio Storti, Università Cattolica del Sacro Cuore, Italy
- Sudhir Tauro, University of Dundee, United Kingdom
- Ramon Tiu, Eli-Lilly and Company, USA
Journal metricsAcceptance rate60%
Submission to final decision69 days
Acceptance to publication24 days
CiteScore-
Impact Factor-
Submit
